Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis

Ozkan T. B., Mistik R., Dikici B., Nazlioglu H. O.

BMC GASTROENTEROLOGY, vol.7, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7
  • Publication Date: 2007
  • Doi Number: 10.1186/1471-230x-7-9
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Bursa Uludag University Affiliated: No


Background: Neonatal hepatitis refers to a heterogeneous group of disorders, caused by many factors including cytomegalovirus infection, revealing similar morphologic changes in the liver of an infant less than 3 months of age. Approximately 40% of cholestasis in infants is due to neonatal hepatitis. It may cause latent or acute cholestatic or chronic hepatitis, including cirrhosis in immunocompetant infant.